FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field and specifically to use of a compound of formula I: 
I, where E1 is H, OH or NH2; E2 is H, OH or NH2; E3 is H, OH or NH2; E4 is H, OH or NH2; A is H or NH2; D is 
; or A and D form 6-member ring of formula: 
; G is N; L1 is OH; for treating a fibrotic disease. Group of inventions also relates to a method of treating a fibrosing disease by administering said compounds; pharmaceutical composition containing said compounds, and commercial package containing said compositions.
EFFECT: group of inventions provides new agents and methods of treating fibrosis.
35 cl, 13 ex, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOUND | 2016 |
|
RU2730842C2 |
| COMBINATION OF KYNURENIN AND ANTIGEN-PRESENTING CELLS (APC) AS THERAPEUTIC AGENTS AND A METHOD FOR USE THEREOF IN IMMUNOMODULATION | 2015 |
|
RU2727573C2 |
| METHOD OF PRODUCING STABLE BACTERIAL EXTRACTS AND USE THEREOF AS PHARMACEUTICAL PREPARATIONS | 2020 |
|
RU2820605C2 |
| MEANS AND METHODS FOR CANCER TREATMENT AND/OR PREVENTION DEPENDING ON NATURAL AHR LIGAND | 2012 |
|
RU2640913C2 |
| NEW BENZAZEPIN DERIVATIVES | 2003 |
|
RU2423353C1 |
| ANTISENSE OLIGONUCLEOTIDES OF MATRIX METALLOPROTEINASE-1 | 2019 |
|
RU2802418C2 |
| SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIODIARYL COMPOUNDS | 2010 |
|
RU2548918C2 |
| ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
| APPLICATION OF FUSED TIMP-GPI CONSTRUCT AND METHOD OF TREATING SKIN INJURES FOR CICATRISATION PREVENTION OR INHIBITION | 2006 |
|
RU2428479C2 |
| BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
